221 related articles for article (PubMed ID: 30763560)
1. Reversal and Resumption of Antithrombotic Therapy in LVAD-Associated Intracranial Hemorrhage.
Cho SM; Moazami N; Katz S; Starling R; Frontera JA
Ann Thorac Surg; 2019 Jul; 108(1):52-58. PubMed ID: 30763560
[TBL] [Abstract][Full Text] [Related]
2. The Dilemma of Resuming Antithrombotic Therapy After Intracranial Hemorrhage in Patients With Left Ventricular Assist Devices.
Santos CD; Matos NL; Asleh R; Dawit S; Rabinstein AA; O'Carroll CB; Li Z; Freeman WD
Neurocrit Care; 2020 Jun; 32(3):822-827. PubMed ID: 31531758
[TBL] [Abstract][Full Text] [Related]
3. Stroke and Intracranial Hemorrhage in HeartMate II and HeartWare Left Ventricular Assist Devices: A Systematic Review.
Cho SM; Moazami N; Frontera JA
Neurocrit Care; 2017 Aug; 27(1):17-25. PubMed ID: 28324260
[TBL] [Abstract][Full Text] [Related]
4. Medical and Surgical Management of Left Ventricular Assist Device-Associated Intracranial Hemorrhage.
Ibeh C; Tirschwell DL; Mahr C; Creutzfeldt CJ
J Stroke Cerebrovasc Dis; 2021 Oct; 30(10):106053. PubMed ID: 34418673
[TBL] [Abstract][Full Text] [Related]
5. Prothrombin Complex Concentrate for Emergent Reversal of Intracranial Hemorrhage in Patients with Ventricular Assist Devices.
Lai GY; Maas MB; Leong CR; Liotta EM; Rich JD; Pham DT; Vorovich EE; Naidech AM; Jahromi BS; Potts MB
Neurocrit Care; 2021 Oct; 35(2):506-517. PubMed ID: 33821403
[TBL] [Abstract][Full Text] [Related]
6. Management of intracranial hemorrhage in patients with left ventricular assist devices.
Wilson TJ; Stetler WR; Al-Holou WN; Sullivan SE; Fletcher JJ
J Neurosurg; 2013 May; 118(5):1063-8. PubMed ID: 23451903
[TBL] [Abstract][Full Text] [Related]
7. Risk factors, mortality, and timing of ischemic and hemorrhagic stroke with left ventricular assist devices.
Frontera JA; Starling R; Cho SM; Nowacki AS; Uchino K; Hussain MS; Mountis M; Moazami N
J Heart Lung Transplant; 2017 Jun; 36(6):673-683. PubMed ID: 28110971
[TBL] [Abstract][Full Text] [Related]
8. Outcomes Associated With Resuming Warfarin Treatment After Hemorrhagic Stroke or Traumatic Intracranial Hemorrhage in Patients With Atrial Fibrillation.
Nielsen PB; Larsen TB; Skjøth F; Lip GY
JAMA Intern Med; 2017 Apr; 177(4):563-570. PubMed ID: 28241151
[TBL] [Abstract][Full Text] [Related]
9. Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage: A Statement for Healthcare Professionals from the Neurocritical Care Society and Society of Critical Care Medicine.
Frontera JA; Lewin JJ; Rabinstein AA; Aisiku IP; Alexandrov AW; Cook AM; del Zoppo GJ; Kumar MA; Peerschke EI; Stiefel MF; Teitelbaum JS; Wartenberg KE; Zerfoss CL
Neurocrit Care; 2016 Feb; 24(1):6-46. PubMed ID: 26714677
[TBL] [Abstract][Full Text] [Related]
10. Management of Intracranial Hemorrhage in Patients with a Left Ventricular Assist Device: A Systematic Review and Meta-Analysis.
Carroll AH; Ramirez MP; Dowlati E; Mueller KB; Borazjani A; Chang JJ; Felbaum DR
J Stroke Cerebrovasc Dis; 2021 Feb; 30(2):105501. PubMed ID: 33271486
[TBL] [Abstract][Full Text] [Related]
11. Management of Antiplatelet Therapy During Continuous-Flow Left Ventricular Assist Device Support After Thrombotic Hemorrhagic Events.
Gallo M; Trivedi JR; Mondal NK; Birks EJ; Slaughter MS
ASAIO J; 2019; 65(7):683-689. PubMed ID: 30585872
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of anticoagulation and nonsurgical major bleeding in recipients of continuous-flow left ventricular assist devices.
Veasey TM; Floroff CK; Strout SE; McElray KL; Brisco-Bacik MA; Cook JL; Toole JM; Craig ML; Van Bakel AB; Meadows HB; Uber WE
Artif Organs; 2019 Aug; 43(8):736-744. PubMed ID: 30868618
[TBL] [Abstract][Full Text] [Related]
13. Safety of anticoagulation reversal in patients supported with continuous-flow left ventricular assist devices.
Jennings DL; Jacob M; Chopra A; Nemerovski CW; Morgan JA; Lanfear DE
ASAIO J; 2014; 60(4):381-4. PubMed ID: 24658518
[TBL] [Abstract][Full Text] [Related]
14. Individualized Antithrombotic Therapy in Heartware HVAD Recipients.
Sorensen EN; Voorhees HJ; Dees LM; Pham SM; Kon ZN; Griffith BP; Feller ED
ASAIO J; 2019 Jan; 65(1):29-35. PubMed ID: 29461279
[TBL] [Abstract][Full Text] [Related]
15. Optimal timing of resumption of warfarin after intracranial hemorrhage.
Majeed A; Kim YK; Roberts RS; Holmström M; Schulman S
Stroke; 2010 Dec; 41(12):2860-6. PubMed ID: 21030703
[TBL] [Abstract][Full Text] [Related]
16. Anti-thrombotic therapy in patients with atrial fibrillation and intracranial hemorrhage.
Diener HC; Stanford S; Abdul-Rahim A; Christensen L; Hougaard KD; Bakhai A; Veltkamp R; Worthmann H
Expert Rev Neurother; 2014 Sep; 14(9):1019-28. PubMed ID: 25091395
[TBL] [Abstract][Full Text] [Related]
17. Relationship Between Anticoagulation Intensity and Thrombotic or Bleeding Outcomes Among Outpatients With Continuous-Flow Left Ventricular Assist Devices.
Nassif ME; LaRue SJ; Raymer DS; Novak E; Vader JM; Ewald GA; Gage BF
Circ Heart Fail; 2016 May; 9(5):. PubMed ID: 27154497
[TBL] [Abstract][Full Text] [Related]
18. Prothrombin complex concentrates to reverse warfarin-induced coagulopathy in patients with intracranial bleeding.
Cabral KP; Fraser GL; Duprey J; Gibbons BA; Hayes T; Florman JE; Seder DB
Clin Neurol Neurosurg; 2013 Jun; 115(6):770-4. PubMed ID: 22835715
[TBL] [Abstract][Full Text] [Related]
19. Comparison of two individualized antithrombotic protocols in HeartWare HVAD recipients.
Sorensen EN; Plazak ME; Dees LM; Klass WJ; Ziegler LA; Ledroux SN; Griffith BP; Feller ED
Artif Organs; 2022 Jan; 46(1):117-127. PubMed ID: 34425001
[TBL] [Abstract][Full Text] [Related]
20. Timing of the resumption of antithrombotic agents following surgical evacuation of chronic subdural hematomas: a retrospective cohort study.
Guha D; Coyne S; Macdonald RL
J Neurosurg; 2016 Mar; 124(3):750-9. PubMed ID: 26361283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
